HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of arsenical keratosis with etretinate.

Abstract
Treatment with oral etretinate is reported in a case of arsenical keratosis with Bowen's disease. Good (80%) clearance in keratoses was obtained, which is maintained after 15 months' follow up.
AuthorsS C Sharma, N B Simpson
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 63 Issue 5 Pg. 449-52 ( 1983) ISSN: 0001-5555 [Print] Sweden
PMID6197851 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Arsenicals
  • Etretinate
Topics
  • Administration, Oral
  • Aged
  • Arsenicals (adverse effects, therapeutic use)
  • Etretinate (administration & dosage, therapeutic use)
  • Humans
  • Keratosis (chemically induced, drug therapy)
  • Male
  • Sleep Initiation and Maintenance Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: